These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 12076461)

  • 1. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter S; Greyber E; Pasternak G; Salpeter E
    Cochrane Database Syst Rev; 2002; (2):CD002967. PubMed ID: 12076461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter S; Greyber E; Pasternak G; Salpeter E
    Cochrane Database Syst Rev; 2003; (2):CD002967. PubMed ID: 12804446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter S; Greyber E; Pasternak G; Salpeter E
    Cochrane Database Syst Rev; 2006 Jan; (1):CD002967. PubMed ID: 16437448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter SR; Greyber E; Pasternak GA; Salpeter Posthumous EE
    Cochrane Database Syst Rev; 2010 Jan; (1):CD002967. PubMed ID: 20091535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter SR; Greyber E; Pasternak GA; Salpeter EE
    Cochrane Database Syst Rev; 2010 Apr; 2010(4):CD002967. PubMed ID: 20393934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis.
    Salpeter SR; Greyber E; Pasternak GA; Salpeter EE
    Arch Intern Med; 2003 Nov; 163(21):2594-602. PubMed ID: 14638559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin in patients with type 2 diabetes and kidney disease: a systematic review.
    Inzucchi SE; Lipska KJ; Mayo H; Bailey CJ; McGuire DK
    JAMA; 2014 Dec 24-31; 312(24):2668-75. PubMed ID: 25536258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Traditional contraindications to the use of metformin -- more harmful than beneficial?].
    Holstein A; Egberts EH
    Dtsch Med Wochenschr; 2006 Jan; 131(3):105-10. PubMed ID: 16418951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactic acidosis induced by metformin: incidence, management and prevention.
    Lalau JD
    Drug Saf; 2010 Sep; 33(9):727-40. PubMed ID: 20701406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse event notifications implicating metformin with lactic acidosis in Australia.
    Huang W; Castelino RL; Peterson GM
    J Diabetes Complications; 2015; 29(8):1261-5. PubMed ID: 26104729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metformin-associated lactic acidosis].
    Orban JC; Ghaddab A; Chatti O; Ichai C
    Ann Fr Anesth Reanim; 2006 Oct; 25(10):1046-52. PubMed ID: 17005358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements.
    van Berlo-van de Laar IR; Vermeij CG; Doorenbos CJ
    J Clin Pharm Ther; 2011 Jun; 36(3):376-82. PubMed ID: 21545617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease.
    Sipahi S; Solak Y; Acikgoz SB; Genc AB; Yildirim M; Yilmaz U; Nalbant A; Tamer A
    Int Urol Nephrol; 2016 Aug; 48(8):1305-1312. PubMed ID: 27102431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study.
    Eppenga WL; Lalmohamed A; Geerts AF; Derijks HJ; Wensing M; Egberts A; De Smet PA; de Vries F
    Diabetes Care; 2014 Aug; 37(8):2218-24. PubMed ID: 24842984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin-associated lactic acidosis: Current perspectives on causes and risk.
    DeFronzo R; Fleming GA; Chen K; Bicsak TA
    Metabolism; 2016 Feb; 65(2):20-9. PubMed ID: 26773926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of lactic acidosis in type 2 diabetes patients using metformin: A case control study.
    Aharaz A; Pottegård A; Henriksen DP; Hallas J; Beck-Nielsen H; Lassen AT
    PLoS One; 2018; 13(5):e0196122. PubMed ID: 29738540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactic acidosis. Lactic acidosis associated with metformin use in treatment of type 2 diabetes mellitus.
    DePalo VA; Mailer K; Yoburn D; Crausman RS
    Geriatrics; 2005 Nov; 60(11):36, 39-41. PubMed ID: 16287340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and lactic acidosis: cause or coincidence? A review of case reports.
    Stades AM; Heikens JT; Erkelens DW; Holleman F; Hoekstra JB
    J Intern Med; 2004 Feb; 255(2):179-87. PubMed ID: 14746555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult metformin toxicity in three patients with profound lactic acidosis.
    Perrone J; Phillips C; Gaieski D
    J Emerg Med; 2011 Mar; 40(3):271-5. PubMed ID: 18571361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactic acidosis in metformin therapy.
    Lalau JD; Race JM
    Drugs; 1999; 58 Suppl 1():55-60; discussion 75-82. PubMed ID: 10576527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.